BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 31256949)

  • 1. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
    Chen ZH; Zhang XP; Zhou TF; Wang K; Wang H; Chai ZT; Shi J; Guo WX; Cheng SQ
    Eur J Surg Oncol; 2019 Nov; 45(11):2188-2196. PubMed ID: 31256949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
    Shen A; Liu M; Zheng D; Chen Q; Wu Z
    Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):142-154. PubMed ID: 31303533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: a meta-analysis.
    Wang L; Ke Q; Lin N; Zeng Y; Liu J
    Scand J Gastroenterol; 2019 May; 54(5):528-537. PubMed ID: 31081401
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion.
    Qi YP; Zhong JH; Liang ZY; Zhang J; Chen B; Chen CZ; Li LQ; Xiang BD
    Am J Surg; 2019 Apr; 217(4):739-744. PubMed ID: 30103903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X; Liu L; Wang D; Li H; Su C; Guo X
    Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
    Peng Z; Chen S; Xiao H; Wang Y; Li J; Mei J; Chen Z; Zhou Q; Feng S; Chen M; Qian G; Peng S; Kuang M
    Radiology; 2019 Jul; 292(1):237-247. PubMed ID: 31135299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
    Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
    Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety.
    Wei W; Jian PE; Li SH; Guo ZX; Zhang YF; Ling YH; Lin XJ; Xu L; Shi M; Zheng L; Chen MS; Guo RP
    Cancer Commun (Lond); 2018 Oct; 38(1):61. PubMed ID: 30305149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma.
    Chen W; Ma T; Zhang J; Zhang X; Chen W; Shen Y; Bai X; Liang T
    HPB (Oxford); 2020 Jun; 22(6):795-808. PubMed ID: 31980307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC.
    Chen SL; Xiao H; Xie ZL; Shen JX; Chen ZB; Wang YQ; Li B; Peng ZW; Kuang M; Lai JM; Peng S
    Eur Radiol; 2020 Jun; 30(6):3473-3485. PubMed ID: 32048035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.
    Zhang XP; Wang K; Li N; Zhong CQ; Wei XB; Cheng YQ; Gao YZ; Wang H; Cheng SQ
    BMC Cancer; 2017 Dec; 17(1):902. PubMed ID: 29282010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis.
    Liang L; Li C; Diao YK; Jia HD; Xing H; Pawlik TM; Lau WY; Shen F; Huang DS; Zhang CW; Yang T
    Therap Adv Gastroenterol; 2020; 13():1756284820977693. PubMed ID: 33329759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resection Plus Post-operative Adjuvant Transcatheter Arterial Chemoembolization (TACE) Compared with Resection Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Huo YR; Chan MV; Chan C
    Cardiovasc Intervent Radiol; 2020 Apr; 43(4):572-586. PubMed ID: 31897617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion.
    Liu S; Li H; Guo L; Zhang B; Zhou B; Zhang W; Zhou J; Fan J; Ye Q
    Oncologist; 2019 Apr; 24(4):513-520. PubMed ID: 30552155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
    Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
    J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion.
    Wang YY; Wang LJ; Xu D; Liu M; Wang HW; Wang K; Zhu X; Xing BC
    HPB (Oxford); 2019 Apr; 21(4):425-433. PubMed ID: 30249510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of microvascular invasion on the postoperative long-term prognosis of solitary small HCC: a systematic review and meta-analysis.
    Chen ZH; Zhang XP; Wang H; Chai ZT; Sun JX; Guo WX; Shi J; Cheng SQ
    HPB (Oxford); 2019 Aug; 21(8):935-944. PubMed ID: 30871805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis.
    Yang J; Liang H; Hu K; Xiong Z; Cao M; Zhong Z; Yao Z; Deng M
    Cancer Cell Int; 2021 Feb; 21(1):92. PubMed ID: 33549093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.